Clobazam Suspension
Product Images NDC 31722-641

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 31722-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120mlcontainercarton (120mlcontainercarton)

Label for Clobazam Oral Suspension 2.5 mg/mL by Camber Pharmaceuticals, Inc. The label includes dosage form (oral suspension), volume (120 mL), NDC 31722-641-12, and administration route (oral). It advises pharmacists to dispense the Medication Guide separately and provides storage instructions and contact information for the manufacturer. The label also indicates the product is Rx only and has instructions to shake before use.*

FDA Label Image

120mlcontainerlabel (120mlcontainerlabel)

Label for Clobazam Oral Suspension 2.5 mg/mL by Camber Pharmaceuticals, Inc. The label states it is a 120 mL bottle for oral administration only. It includes storage instructions, dosage form, and a barcode. The label emphasizes the prescription-only status and provides contact information and a link to the medication guide.*

FDA Label Image

Camber (Camber)

FDA Label Image

Figure-a (Figure A)

Clobazam 2.5 mg/mL oral suspension by Camber Pharmaceuticals, Inc. The image shows a brown glass bottle with a white cap and label, packaged alongside a white box with red accents. The box displays the product name, strength, route, and administration instruction. Also included are two purple oral syringes and a white bottle adapter for dosing. The bottle size is 120 mL.*

FDA Label Image

Figure-b (Figure B)

Clobazam oral suspension 2.5 mg/mL in a 120 mL amber glass bottle with a white child-resistant cap, labeled by Camber Pharmaceuticals, Inc. The label includes directions to shake well before use and states it is for oral administration and prescription only.*

FDA Label Image

Figure-c (Figure C)

An instructional illustration showing a close-up of a brown glass bottle with a white child-resistant cap being removed by downward pressure, demonstrating proper opening technique for oral suspension medication containers.*

FDA Label Image

Figure-d (Figure D)

An illustrated diagram of an oral syringe for Clobazam suspension, showing labeled parts including the tip, dosage indicators on the barrel, the barrel itself, a violet ring on the plunger, and the plunger. This syringe design supports accurate dosing of the 2.5 mg/mL oral suspension.*

FDA Label Image

Figure-e (Figure E)

An instructional illustration showing a purple oral dosing syringe being inserted into the neck of a brown prescription bottle containing Clobazam oral suspension, 2.5 mg/mL. A hand holds the syringe, and a black arrow indicates the direction of insertion downward into the bottle.*

FDA Label Image

Figure-f (Figure F)

An instructional illustration showing a brown oral suspension bottle being poured into a purple measuring syringe. The image demonstrates how to draw the suspension from the bottle into the syringe for oral administration, with a downward arrow indicating the direction of liquid flow.*

FDA Label Image

Figure-g (Figure G)

An instructional image showing a dosing syringe containing purple suspension medication. A note with an arrow indicates to measure the suspension up to the violet ring on the syringe for accurate dosing.*

FDA Label Image

Figure-h (Figure H)

An instructional image showing an oral administration of Clobazam suspension to a young child using a syringe. The child is receiving the medicine by mouth, demonstrating proper dosing technique with a liquid medication.*

FDA Label Image

Figure-i (Figure I)

Clobazam Oral Suspension 2.5 mg/mL in a brown glass bottle with a white child-resistant cap. The label shows the product name, strength, and labeler Camber Pharmaceuticals, Inc., along with an NDC code 31722-641-12. The image includes a hand gripping the cap, indicating the opening mechanism.*

FDA Label Image

Graph (Graph)

A bar graph showing the percent reduction in weekly drop seizures across four groups: Placebo, Low, Medium, and High doses of Clobazam. The bars indicate increasing seizure reduction with higher doses, ranging from -12.1% for placebo to -68.3% for the high dose. Statistical significance is indicated for Low (* p<0.05), Medium (** p<0.01), and High (** p<0.01) dose groups compared to placebo.*

FDA Label Image

Graph2 (Graph2)

A bar chart showing the proportion of patients (%) on the vertical axis and reduction in weekly drop seizure frequency from baseline (%) on the horizontal axis. The chart compares placebo and three dosing levels of Clobazam (Low, Medium, High) across various ranges of seizure reduction.*

FDA Label Image

Structure (Structure)

Chemical structure of clobazam, showing its molecular framework including a chlorinated benzodiazepine ring fused with a diazepine moiety and a phenyl group attached to the diazepine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.